Heterogeneous behavior of anti-β2-glycoprotein I antibodies on various commercially available enzyme immunoassay plates coated with β2- glycoprotein I

Journal of Rheumatology

Volumn 27, Issue 2, 2000, Pages 391-396

  Tsutsumi, Akito ^a   Ichikawa, Kenji ^b   Matsuura, Eiji ^b   Sawada, Ken ichi ^b   Koike, Takao ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NONE

Author keywords

Anti 2 glycoprotein I antibodies; Antiphospholipid Syndrome; Enzyme Immunoassay

Indexed keywords

BETA2 GLYCOPROTEIN 1; MONOCLONAL ANTIBODY;

ANTIBODY RESPONSE; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION;

ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; GLYCOPROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; SENSITIVITY AND SPECIFICITY;

EID: 0033975598     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990;87:4120-4.
2. Galli M, Comfurius P, Maassen C, et al. Anticardiolipin antibodies directed not to cardiolipin but to a plasma cofactor. Lancet 1990;335:1544-7.
3. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990;336:177-8.
4. Koike T, Matsuura E. What is the "true" antigen for anticardiolipin antibodies? Lancet 1991;337:671-2.
5. Matsuura E, Igarashi Y, Fujimoto M, et al. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol 1992;148:3885-91.
6. 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994;179:457-62.
7. 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus. Arthritis Rheum 1996;39:1466-74.
8. 2-glycoprotein I in patients with systemic lupus erythematosus [reply]. Arthritis Rheum 1997;40:1366-7.
9. 2-glycoprotein I in patients with systemic lupus erythematosus. J Rheumatol 1998;25:74-8.
10. 2-glycoprotein-I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis. Br J Haematol 1995;91:471-7.
11. 2-glycoprotein I is bound to a suitable surface. Thromb Haemost 1995;73:29-34.
12. 2-glycoprotein I in patients with antiphospholipid syndrome. Br J Rheumatol 1996;35:1239-43.
13. 2-glycoprotein I - a specific marker for the antiphospholipid syndrome. Clin Exp Immunol 1997;109:304-9.
14. 2-glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome. Arthritis Rheum 1994;37:1453-61.
15. 2-glycoprotein I as an anticardiolipn cofactor determined using deleted mutants expressed by a baculovirus system. Blood 87:3262-70.
16. 2GPI in antibody binding. J Immunol 1998;160:3917-23.
17. 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding. J Immunol 1995;154:954-60.